Fingolimod -Response According to Coping - Evaluation
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is a prospective, open-label, multi-center phase IV study to assess response to
fingolimod initiation according to coping profile in adult patients with highly active
relapsing remitting multiple sclerosis in France.